News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
497,590 Results
Type
Article (9964)
Company Profile (158)
Press Release (487467)
Multimedia
Podcasts (18)
Webinars (7)
Section
Business (171328)
Career Advice (365)
Deals (26346)
Drug Delivery (15)
Drug Development (54231)
Employer Resources (22)
FDA (9938)
Job Trends (8949)
News (244106)
Policy (18355)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (597)
Accelerated approval (24)
ADA (21)
Adcomms (1)
Allergies (100)
Alliances (34445)
ALS (110)
Alzheimer's disease (1011)
Antibody-drug conjugate (ADC) (299)
Approvals (10543)
Artificial intelligence (357)
ASCO (166)
Autoimmune disease (215)
Automation (32)
Bankruptcy (269)
Best Places to Work (7144)
BIO (41)
Biologics (2)
BIOSECURE Act (3)
Biosimilars (127)
BioSpace Insights (27)
Biotechnology (99)
Bladder cancer (141)
Brain cancer (34)
Breast cancer (520)
Cancer (3816)
Cardiovascular disease (227)
Career advice (296)
Career pathing (2)
CAR-T (187)
CDC (2)
Celiac Disease (1)
Cell therapy (523)
Cervical cancer (38)
Clinical research (48858)
Collaboration (1371)
Commercialization (3)
Company closure (4)
Compensation (1484)
Complete response letters (35)
COVID-19 (893)
CRISPR (69)
C-suite (831)
Cystic fibrosis (91)
Data (5811)
Denatured (10)
Depression (110)
Dermatology (63)
Diabetes (359)
Diagnostics (4329)
Digital health (39)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (187)
Drug pricing (16)
Drug shortages (2)
Duchenne muscular dystrophy (186)
Earnings (74369)
Editorial (6)
Employer branding (3)
Employer resources (20)
Events (89297)
Executive appointments (756)
FDA (12616)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (1051)
Gene editing (142)
Generative AI (12)
Gene therapy (359)
GLP-1 (347)
Government (1065)
Grass and pollen (2)
Guidances (285)
Healthcare (9565)
Hematology (95)
HIV (54)
Huntington's disease (24)
IgA nephropathy (66)
Immunology and inflammation (134)
Immuno-oncology (69)
Indications (158)
Infectious disease (1098)
Inflammatory bowel disease (135)
Inflation Reduction Act (8)
Influenza (89)
Intellectual property (263)
Interviews (47)
IPO (12590)
IRA (7)
Job creations (2140)
Job search strategy (281)
JPM (5)
Kidney cancer (20)
Labor market (12)
Layoffs (106)
Leadership (3)
Legal (5298)
Licensing (8)
Liver cancer (48)
Longevity (20)
Lung cancer (526)
Lymphoma (258)
Machine learning (30)
Management (7)
Manufacturing (575)
Marketing (8)
MASH (122)
Medical device (8751)
Medtech (8896)
Mergers & acquisitions (14807)
Metabolic disorders (757)
mRNA (66)
Multiple sclerosis (106)
NASH (4)
Neurodegenerative disease (241)
Neuropsychiatric disorders (49)
Neuroscience (1930)
NextGen: Class of 2026 (3345)
Non-profit (974)
Now hiring (15)
Obesity (251)
Opinion (30)
Ovarian cancer (161)
Pain (178)
Pancreatic cancer (213)
Parkinson's disease (211)
Partnered (15)
Patents (489)
Patient recruitment (524)
Peanut (32)
People (42925)
Pharmaceutical (31)
Pharmacy benefit managers (8)
Phase 1 (15923)
Phase 2 (21893)
Phase 3 (14751)
Pipeline (7543)
Policy (33)
Postmarket research (1581)
Preclinical (6738)
Press Release (34)
Prostate cancer (192)
Psychedelics (12)
Radiopharmaceuticals (199)
Rare diseases (625)
Real estate (3265)
Recruiting (10)
Regulatory (15229)
Reports (25)
Research institute (686)
Resumes & cover letters (53)
Rett syndrome (42)
RNA editing (8)
RSV (51)
Schizophrenia (110)
Series A (192)
Series B (139)
Service/supplier (5)
Sickle cell disease (65)
Special edition (3)
Spinal muscular atrophy (89)
Sponsored (6)
Startups (2291)
Stomach cancer (5)
Supply chain (52)
Tariffs (2)
The Weekly (8)
Vaccines (366)
Venture capital (37)
Weight loss (95)
Women's health (83)
Worklife (1)
Date
Today (42)
Last 7 days (220)
Last 30 days (1631)
Last 365 days (19802)
2026 (12818)
2025 (20005)
2024 (23640)
2023 (27245)
2022 (35547)
2021 (38254)
2020 (34534)
2019 (24074)
2018 (18179)
2017 (19388)
2016 (18554)
2015 (24830)
2014 (22074)
2013 (18607)
2012 (20699)
2011 (20859)
2010 (20704)
Location
Africa (251)
Alabama (76)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (19048)
Australia (2290)
California (12311)
Canada (3199)
China (587)
Colorado (492)
Connecticut (417)
Delaware (212)
Europe (27314)
Florida (1803)
Georgia (381)
Hawaii (4)
Idaho (47)
Illinois (724)
India (55)
Indiana (323)
Iowa (15)
Japan (411)
Kansas (111)
Kentucky (31)
Louisiana (29)
Maine (26)
Maryland (1221)
Massachusetts (8069)
Michigan (313)
Minnesota (573)
Mississippi (5)
Missouri (85)
Montana (20)
Nebraska (11)
Nevada (117)
New Hampshire (63)
New Jersey (2672)
New Mexico (12)
New York (2847)
North Carolina (1300)
North Dakota (4)
Northern California (6189)
Ohio (292)
Oklahoma (15)
Oregon (21)
Pennsylvania (2268)
Puerto Rico (21)
Rhode Island (31)
South America (426)
South Carolina (76)
South Dakota (1)
Southern California (5072)
Tennessee (126)
Texas (1987)
United States (39760)
Utah (364)
Vermont (1)
Virginia (160)
Washington D.C. (41)
Washington State (984)
West Virginia (2)
Wisconsin (85)
Wyoming (1)
497,590 Results for "meridian bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Meridian Bioscience Announces Health Canada License for Alethia® CMV Assay
July 14, 2026
·
3 min read
Press Releases
Meridian Bioscience and 4bases Announce Collaboration to Enable Rapid, Globally Scalable Next-Generation Sequencing Workflows
June 10, 2026
·
5 min read
Press Releases
Meridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay Portfolio
February 24, 2026
·
2 min read
Press Releases
Meridian Bioscience Appoints New CEO and Executive Team to Accelerate Global Growth
October 15, 2025
·
4 min read
Press Releases
Meridian Bioscience Eliminates Cold Chain with the First Liquid Ambient Temperature Stable qPCR Master Mixes
September 17, 2025
·
4 min read
Press Releases
Meridian Life Science Expands Ambient-Stable NGS Portfolio with the Launch of a Lyophilized Enzymatic DNA Fragmentation Kit
February 18, 2026
·
4 min read
Press Releases
Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
August 4, 2026
·
14 min read
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
The star of the takeover is Forte Biosciences’ investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease.
July 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Meridian Bioscience Introduces New Enzyme Stabilization Services for Molecular Diagnostics
April 23, 2025
·
4 min read
Press Releases
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
August 6, 2026
·
10 min read
1 of 49,759
Next
